Estimating Progression Rate and Distinguishing Parkinsonian Syndromes Using Imaging and Deep Learning

Estimating Progression Rate and Distinguishing Parkinsonian Syndromes Using Imaging and Deep Learning

Publication date: Mar 13, 2019

The goal of this study is to develop a model to predict the progression rate of Parkinson disease (PD) and use this model to distinguish between similar diseases such as PD, Progressive Supranuclear Palsy (PSP), and Multiple System Atrophy (MSA).

Concepts Keywords
Alcohol Chemotherapy
Allergic Reaction Progressive supranuclear palsy
Aphasia Electroencephalography
Ataxia Medical imaging
Atrophy Radiation
Autonomic MRI
Biomarker Multiple system atrophy
Blood Pressure Electrophysiology
Brain Injury Neurodegenerative disorders
Bulbar Branches of biology
Cerebellar Rare diseases
Chemotherapy Cognitive disorders
Cohort Psychiatric diagnosis
Comorbidity Medicine
Contractures Neurological disorders
DaT Chemotherapy
Deep Learning Radiation
Dementia Symptomatic orthostatic hypotension
Diastolic Hypersensitivity
Differential Diagnosis Visual hallucinations
Dopamine Psychiatric neurological disorder
Dopaminergic Severe allergic reaction
Dystonic Inspiratory respiratory dysfunction
EEG Drug allergy
Encephalitis Early bulbar dysfunction
Encephalopathies Orthostatic hypotension
Episodic Memory Multimodal imaging
Etiology
Eye Movements
Frontotemporal Dementia
Gait
Hormone
Hyperreflexia
Hypersensitivity
Indicative
Informed Consent
Iodine
Kidney
Levodopa
Lewy Bodies
Liver
Lung
MEG
Modal
Motor Neuron
MRI
Multimodal
Multiple System Atrophy
Neurodegenerative
Neuroimaging
Neurological Disorder
Orthostatic Hypotension
Parkinson
Parkinsonian
Parkinsonian Symptoms
Parkinsonism
Postural Instability
Predictive Model
Pregnancy Test
Presynaptic
Prion
Progressive
Progressive Supranuclear Palsy
PSP
Pyramidal Tract
Radiation
Saccades
Severe Allergic Reaction
Spasticity
SPECT
Stridor
Substance Dependence
Supranuclear Palsy
Symmetric
Syndrome
Systolic
Texas
Upper Motor Neuron
Vestibular
Visual Hallucinations
Wheelchair

Semantics

Type Source Name
disease MESH appendicular ataxia
disease DOID encephalitis
disease MESH encephalitis
disease DOID prion disease
disease MESH prion disease
disease MESH encephalopathies
disease MESH autoimmune encephalitis
gene UNIPROT PTPN5
disease DOID motor neuron disease
disease MESH motor neuron disease
disease MESH hallucinations
disease MESH visual
disease DOID Lewy body disease
disease MESH Lewy body disease
disease MESH hyperreflexia
disease MESH contractures
disease MESH stridor
disease DOID syndrome
gene UNIPROT ALG3
gene UNIPROT NR4A2
drug DRUGBANK Levodopa
drug DRUGBANK Dopamine
disease MESH primary progressive aphasia
disease DOID frontotemporal dementia
disease MESH frontotemporal dementia
disease MESH abnormalities
drug DRUGBANK Iodine
disease MESH disease progression
disease MESH neurological disorder
gene UNIPROT EHD1
disease DOID cancer
disease MESH cancer
disease DOID substance dependence
disease MESH substance dependence
drug DRUGBANK Ethanol
disease DOID hypersensitivity
disease MESH hypersensitivity
disease DOID drug allergy
disease MESH drug allergy
disease MESH comorbidity
pathway BSID Infectious disease
disease DOID infectious disease
disease MESH infectious disease
disease MESH heart disease
disease DOID heart disease
gene UNIPROT PTPN4
gene UNIPROT CYREN
disease MESH contraindications
disease MESH orthostatic hypotension
drug DRUGBANK Isoxaflutole
disease MESH gait
disease DOID neurodegenerative disease
drug DRUGBANK Iobenguane
disease MESH neurodegenerative disease
disease MESH diagnosis
gene UNIPROT ASXL1
gene UNIPROT PAFAH1B1
gene UNIPROT TET2
gene UNIPROT YWHAE
disease DOID MDS
gene UNIPROT SF3B1
gene UNIPROT FASTK
gene UNIPROT TPO
disease DOID Multiple System Atrophy
disease MESH Multiple System Atrophy
gene UNIPROT MSMB
gene UNIPROT REG1A
gene UNIPROT PSPN
gene UNIPROT BPIFA2
gene UNIPROT PSPH
gene UNIPROT RIDA
gene UNIPROT STXBP3
disease MESH PSP
disease MESH Progressive Supranuclear Palsy
disease DOID Progressive Supranuclear Palsy
disease DOID Parkinson disease
disease MESH Parkinson disease
disease MESH Syndromes

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *